UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
1476
DELISTED
Select Medical
SEM
| $1.99M | ﹤0.01% |
250,322
-23,690
| -9% | -$196K |
|
1477
Dorman Products
DORM
$4.18B
| $1.98M | ﹤0.01% |
29,508
+728
| +3% | +$46.8K |
|
|
MDLA
1478
DELISTED
Medallia, Inc.
MDLA
| $1.98M | ﹤0.01% |
78,332
+47,155
| +151% | +$1.13M |
|
|
SIX
1479
DELISTED
Six Flags Entertainment Corp.
SIX
| $1.97M | ﹤0.01% |
102,635
-31,058
| -23% | -$618K |
|
1480
Pediatrix Medical
MD
$2.2B
| $1.96M | ﹤0.01% |
114,666
-65,717
| -36% | -$974K |
|
1481
Prestige Consumer Healthcare
PBH
$2.6B
| $1.94M | ﹤0.01% |
51,746
-1,570
| -3% | -$62.8K |
|
1482
Evertec
EVTC
$1.78B
| $1.94M | ﹤0.01% |
69,067
+6,636
| +11% | +$176K |
|
1483
Plug Power
PLUG
$3.04B
| $1.93M | ﹤0.01% |
235,112
+7,164
| +3% | +$33.5K |
|
|
WCC
1484
WESCO International
WCC
$17.7B
| $1.93M | ﹤0.01% |
54,830
-70,752
| -56% | -$2.11M |
|
1485
M/I Homes
MHO
$3.84B
| $1.92M | ﹤0.01% |
55,875
-1,990
| -3% | -$54.5K |
|
1486
Rambus
RMBS
$11B
| $1.92M | ﹤0.01% |
126,023
+25,745
| +26% | +$363K |
|
1487
CarGurus
CARG
$3.47B
| $1.91M | ﹤0.01% |
75,498
-6,526
| -8% | -$152K |
|
1488
Albany International
AIN
$1.78B
| $1.91M | ﹤0.01% |
32,591
+1,665
| +5% | +$90K |
|
1489
Progress Software
PRGS
$1.76B
| $1.91M | ﹤0.01% |
49,364
+2,189
| +5% | +$83.4K |
|
1490
Korn Ferry
KFY
$4.28B
| $1.91M | ﹤0.01% |
62,156
+1,996
| +3% | +$57.1K |
|
1491
Graham Holdings Company
GHC
$5.02B
| $1.9M | ﹤0.01% |
5,558
-1,376
| -20% | -$484K |
|
1492
MACOM Technology Solutions
MTSI
$23.7B
| $1.9M | ﹤0.01% |
55,425
+7,610
| +16% | +$222K |
|
|
ESGR
1493
DELISTED
Enstar Group
ESGR
| $1.9M | ﹤0.01% |
12,453
-533
| -4% | -$78.6K |
|
|
BECN
1494
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $1.89M | ﹤0.01% |
71,769
-6,162
| -8% | -$138K |
|
1495
Capitol Federal Financial
CFFN
$1.1B
| $1.89M | ﹤0.01% |
171,373
-11,248
| -6% | -$129K |
|
1496
ePlus
PLUS
$2.34B
| $1.88M | ﹤0.01% |
53,314
+31,604
| +146% | +$1.08M |
|
1497
Sunrun
RUN
$2.46B
| $1.88M | ﹤0.01% |
95,474
-1,880
| -2% | -$28.8K |
|
|
FSP
1498
Franklin Street Properties
FSP
$46.8M
| $1.88M | ﹤0.01% |
369,248
-3,283
| -0.9% | -$17.4K |
|
|
TPTX
1499
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.88M | ﹤0.01% |
29,083
+19,583
| +206% | +$1.13M |
|
|
WDR
1500
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.88M | ﹤0.01% |
121,101
+9,451
| +8% | +$130K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.